Trial intelligence / Profile preview

PRP for Healing of Operated Sacrococcygeal Pilonidal Sinus

NCT04430413Completed

Sponsor
Kafrelsheikh University
Start
Dec 2018
Primary completion
Dec 2019
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

Randomised, open-label trial of autologous platelet-rich plasma in pilonidal sinus disease (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Assessment of the wound capacity at 1 year. Started Dec 2018; status: completed.

02

Drugs

autologous platelet-rich plasma
03

Conditions

pilonidal sinus disease

Beyond the preview

Go deeper on NCT04430413.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04430413.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call